Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,502 total articles
Snowflake's pullback has compressed downside and left valuation and technical indicators that favor a measured long. With positive cash flow, large enterprise deals showing up, and momentum indicators turning constructive, a mid-term trade to $200 offers a sensible risk-reward if you protect capital with a disciplined stop.
ORIX (IX) offers a pragmatic swing trade: enter around today's price to play upside from expected better-than-consensus results and constructive guidance. The company trades at a modest valuation (PE 14.3, PB 1.48) with a $41.7B market cap and improving technical momentum. Target and stop are defined to keep reward/risk favorable while acknowledgin…
Affirm is reporting GAAP profitability and meaningful free cash flow even as its shares trade at premium multiples (P/E ~80, P/S ~17.4). That combination explains investor enthusiasm, but it also makes the stock vulnerable to a re-rate if growth disappoints or credit costs tick up. We lay out a mid-term short trade with precise entry, stop and targ…
IBM's hybrid cloud and AI-infused infrastructure business is showing the kind of cash-flow improvement and margin leverage investors have been waiting for. At roughly $205B market cap and trading near $218, the stock still offers upside if execution continues; this trade idea lays out a concrete entry, stop and target for a long trade over the next…
Novo Nordisk's rebound is being driven by strong data and adoption for its oral Wegovy and next-gen obesity candidates. The pullback is over; fundamentals and valuation leave room for a measured long trade. Entry $46.00, stop $42.00, target $56.00 for a mid-term push tied to product uptake and continued data flow.
Roblox dropped sharply after management trimmed full-year bookings guidance in early May. That reset pushed the stock to near its 52-week low and left the business trading at equity-market prices that now reflect slower growth. With $1.5B of free cash flow, a $31.3B market cap and user traction still strong, this is a high-risk, high-reward long tr…
Constellation Energy is the U.S. nuclear backbone at the moment the market is scrambling for reliable, low-carbon megawatts to feed AI data centers. Q1 revenue and EPS beat, a completed Calpine acquisition, and explicit guidance put the company on a path to meaningful earnings growth. Given the enterprise value of roughly $105 billion, limited free…
Compass Pathways (CMPS) is trading near $10.70 with a market cap just above $1.0B after a regulatory shift and two positive Phase 3 readouts for COMP360. Technical momentum, falling short interest days-to-cover, and a compressed valuation versus potential revenue per patient support a long trade. We lay out an entry at $10.70, stop at $8.50 and a t…
Abaxx has cleared several execution questions after launching its physically-settled LNG and carbon futures and showing persistent share-price strength. That progression makes a controlled, swing-oriented long plausible, but the company's $1.54B market cap and thin fundamentals leave little margin for error. Trade with a defined stop and realistic …
Ollie's (OLLI) looks like a reasonable long setup after a recent washout: free cash flow of $194.7M, no net debt, and store expansion that drove double-digit sales growth in 2025. At ~19x earnings and EV/EBITDA ~12, the stock offers asymmetric upside to a reasonable target price of $105 while keeping risk limited with a $71 stop.
Phillips 66 (PSX) has the operational footprint and balance-sheet flexibility to compound returns while refiners enjoy one of the strongest crack-spread environments in years. Enter a constructive long here with a clear stop and a target that captures the next leg of the rally while acknowledging material macro and mark-to-market risks.
NextPower's acquisition of Apex positions the company squarely in the data-center infrastructure wave. That strategic pivot can justify a higher multiple if execution and margin expansion follow, yet the stock has already rallied sharply. This trade idea outlines a mid-term swing entry with a tight stop to capture continued rerating while limiting …
ServiceNow has been punished this year on fears that agentic models and competitive AI will hollow out traditional SaaS economics. The numbers suggest a different story: durable subscription revenue, healthy free cash flow ($4.63B), and a pathway to materially higher ARR via Now Assist. I see an asymmetric long setup with a clear entry, stop and a …
Sagimet (SGMT) is a clinical-stage biotech with a differentiated oral FASN inhibitor, denifanstat, that has now cleared several clinical hurdles across MASH and acne. The balance sheet, visible insider/management upgrades, and recent positive Phase 3 acne readouts from partner Ascletis create an asymmetric setup. This trade idea outlines an entry o…
First Hawaiian (FHB) is a regional bank with a concentrated Hawaii franchise that should be an early beneficiary of a more hawkish Fed through wider net interest margins and stronger net interest income. At roughly $3.24B market cap, P/E ~11.5 and P/B ~1.16, the stock appears inexpensive versus its own history and offers a ~3.9% yield. This trade t…
Brookfield Infrastructure represents a portfolio of high-quality, regulated and contracted infrastructure assets that have been repriced lower on macro worries. With the market offering a lower entry point, this trade seeks to capture a mean reversion in valuation and distribution support over a 180 trading day horizon while using a tight stop to l…
Red Violet reported solid top-line momentum and is cash-flow positive, yet trades well below prior highs and at conservative enterprise multiples for a high-growth software business. Upcoming investor conferences and recurring-revenue visibility create a clear path for multiple re-rating. This is a long trade designed for a position horizon (46-180…
Amazon is the easiest way to play continued hyperscaler spending and retail recovery without overpaying for future growth. The stock trades at a reasonable P/E of 32, sports a market cap near $2.9T and 20% ROE, and recent product pivots (Alexa for Shopping) reframe monetization in retail search. We prefer a long with an entry at $268.14, stop at $2…
Klarna is one of the few BNPL platforms with global scale, merchant distribution and a broad consumer product suite. Given its relative pricing versus peers and continued product monetization levers, this trade targets asymmetric upside. Entry at $6.50 with a $10.50 long-term target and a $4.50 stop balances upside capture with risk control.
Advanced Micro Devices has been a primary driver of the recent chip-led rally. Fundamentals and data-center wins justify a bullish view, but stretched multiples and narrow market breadth demand discipline. This trade lays out an entry at $445.50, a protective stop at $410.00 and a primary target of $520.00 over a mid-term (45 trading days) horizon.
Fair Isaac (FICO) is showing accelerating earnings and robust free cash flow that the market is not fully valuing. At roughly $1,100 per share and a market cap near $25.6B, the combination of high FCF, a 33x P/E, and a defensible competitive position argues for a re-rating toward prior multiples. This trade plan targets $1,500 over a 180-trading-da…
Micron has gone from an unloved memory vendor to the leading beneficiary of AI-driven demand for DRAM, HBM and NAND. Fundamentals and free cash flow support continued upside, but technicals and concentrated market breadth argue for a disciplined trade with a clear stop. We outline a mid-term (45 trading days) buy plan, valuation context, catalysts …
Vishay is benefitting from a snapback in passive and discrete demand, fresh product ramps for automotive and industrial applications, and an improving balance-sheet profile. The chart shows momentum but is extended; this plan buys the recovery with a clear entry, stop, and mid-term target while acknowledging valuation and cash-flow risks.
USA Rare Earth is assembling a vertically integrated rare‑earth platform via the $2.8B Serra Verde acquisition, a $1.5B PIPE and early production milestones. The balance sheet and government interest give the company runway; we look to buy into a 180‑day thesis that execution and offtake visibility will drive a re‑rating.
UnitedHealth (UNH) has been through a rough patch — membership resets, cost overshoots, and an earnings reset in 2025 — but recent operational progress and a large cash flow base make the stock a tactical buy for a position trade. This idea lays out an entry at $399.97, a protective stop at $372.00, and a realistic target at $440.00 with a time hor…
